Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Testing effectiveness (Phase 2)Study completedNCT00333502What this trial is testingStudy of CRLX101 (NLG207) in the Treatment of Advanced Solid TumorsWho this might be right forCancerSolid Tumor NewLink Genetics Corporation 62
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Study completedNCT00060372What this trial is testingIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive CancerWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more National Cancer Institute (NCI) 21
Not applicableUnknownNCT03517332What this trial is testingCirculating Tumor DNA Exposure in Peripheral BloodWho this might be right forColorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more Quantgene Inc. 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT06953089What this trial is testingDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsWho this might be right forSolid Tumors DualityBio Inc. 492
Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Not applicableWithdrawnNCT01558778What this trial is testingMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272What this trial is testingA Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid MalignanciesWho this might be right forSolid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more 23andMe, Inc. 141
Early research (Phase 1)Study completedNCT03538028What this trial is testingA Safety and Tolerability Study of INCAGN02385 in Select Advanced MalignanciesWho this might be right forCervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more Incyte Biosciences International Sàrl 22
Not applicableWithdrawnNCT00898612What this trial is testingEarly Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forLymphoma Mayo Clinic
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Study completedNCT02307500What this trial is testingRegorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard TherapyWho this might be right forPancreas CancerOvarian CancerMelanoma+4 more Istituto Clinico Humanitas 82
Early research (Phase 1)Study completedNCT00027534What this trial is testingVaccine Therapy in Treating Patients With Advanced or Metastatic CancerWho this might be right forBreast CancerColorectal CancerGallbladder Cancer+6 more Michael Morse, MD 14
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT01178411What this trial is testingAn Extension Protocol for Subjects Who Were Previously Enrolled in Other Tivantinib (ARQ 197) ProtocolsWho this might be right forAdvanced Solid Tumors ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 60